Mizuho Medy Co.,Ltd. (4595.T)
JPY 1482.0
(-0.47%)
JPY 1482.0
(-0.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.15 Billion JPY | -53.6% |
| 2022 | 11.1 Billion JPY | 65.77% |
| 2021 | 6.69 Billion JPY | 1509.36% |
| 2020 | 416.22 Million JPY | -62.54% |
| 2019 | 1.11 Billion JPY | -8.98% |
| 2018 | 1.22 Billion JPY | 43.54% |
| 2017 | 850.43 Million JPY | 60.63% |
| 2016 | 529.43 Million JPY | 36.34% |
| 2015 | 388.33 Million JPY | -16.5% |
| 2014 | 465.08 Million JPY | 132.54% |
| 2013 | 200 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 591 Million JPY | -52.83% |
| 2024 Q1 | 1.25 Billion JPY | -8.05% |
| 2023 Q4 | 1.36 Billion JPY | -27.74% |
| 2023 Q2 | 875.75 Million JPY | -14.78% |
| 2023 Q3 | 1.88 Billion JPY | 115.34% |
| 2023 FY | 5.15 Billion JPY | -53.6% |
| 2023 Q1 | 1.02 Billion JPY | -57.32% |
| 2022 Q2 | 1.83 Billion JPY | -33.2% |
| 2022 Q3 | 4.12 Billion JPY | 124.83% |
| 2022 Q4 | 2.4 Billion JPY | -41.56% |
| 2022 FY | 11.1 Billion JPY | 65.77% |
| 2022 Q1 | 2.74 Billion JPY | 166.48% |
| 2021 Q4 | 1.02 Billion JPY | -59.54% |
| 2021 Q3 | 2.54 Billion JPY | 13.23% |
| 2021 Q2 | 2.24 Billion JPY | 155.97% |
| 2021 FY | 6.69 Billion JPY | 1509.36% |
| 2021 Q1 | 877.83 Million JPY | 33.93% |
| 2020 Q4 | 655.43 Million JPY | 696.25% |
| 2020 Q3 | -109.92 Million JPY | 13.78% |
| 2020 Q2 | -127.5 Million JPY | -7030.87% |
| 2020 Q1 | -1.78 Million JPY | -100.31% |
| 2020 FY | 416.22 Million JPY | -62.54% |
| 2019 Q2 | 52.27 Million JPY | -86.32% |
| 2019 FY | 1.11 Billion JPY | -8.98% |
| 2019 Q4 | 580.75 Million JPY | 505.77% |
| 2019 Q3 | 95.86 Million JPY | 83.38% |
| 2019 Q1 | 382.17 Million JPY | -29.77% |
| 2018 FY | 1.22 Billion JPY | 43.54% |
| 2018 Q3 | 97.83 Million JPY | 261.04% |
| 2018 Q1 | 551.61 Million JPY | 2.44% |
| 2018 Q2 | 27.09 Million JPY | -95.09% |
| 2018 Q4 | 544.16 Million JPY | 456.18% |
| 2017 Q3 | 12.13 Million JPY | 2.22% |
| 2017 FY | 850.43 Million JPY | 60.63% |
| 2017 Q1 | 287.95 Million JPY | -39.02% |
| 2017 Q4 | 538.47 Million JPY | 4338.14% |
| 2017 Q2 | 11.86 Million JPY | -95.88% |
| 2016 Q3 | -83.18 Million JPY | -70.35% |
| 2016 Q4 | 472.23 Million JPY | 667.7% |
| 2016 Q1 | 189.22 Million JPY | -38.08% |
| 2016 FY | 529.43 Million JPY | 36.34% |
| 2016 Q2 | -48.83 Million JPY | -125.81% |
| 2015 FY | 388.33 Million JPY | -16.5% |
| 2015 Q4 | 305.56 Million JPY | 0.0% |
| 2014 FY | 465.08 Million JPY | 132.54% |
| 2013 FY | 200 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -0.763% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 97.593% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.455% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 96.995% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 2735.14% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 83.585% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 45.843% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 90.354% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -619.551% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 60.872% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 11.219% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -162.321% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 1142.913% |
| Tsumura & Co. | 20.01 Billion JPY | 74.263% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -28.255% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -2.303% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 70.807% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -33.54% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 46.978% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 14.319% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 267.327% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -32.306% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 734.741% |
| MedRx Co., Ltd | -933 Million JPY | 652.196% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 552.326% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 317.383% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 20.739% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 72.721% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 838.703% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 73.349% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -17.563% |